
Drospirenone
CAS No. 67392-87-4
Drospirenone( 1,2-dihydro Spirorenone | ZK 30595 )
Catalog No. M15569 CAS No. 67392-87-4
Drospirenone is a synthetic progestin that is an analog to spironolactone. It is found in a number of birth control formulations.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 39 | In Stock |
![]() ![]() |
25MG | 70 | In Stock |
![]() ![]() |
50MG | 120 | In Stock |
![]() ![]() |
100MG | 195 | In Stock |
![]() ![]() |
200MG | 291 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDrospirenone
-
NoteResearch use only, not for human use.
-
Brief DescriptionDrospirenone is a synthetic progestin that is an analog to spironolactone. It is found in a number of birth control formulations.
-
DescriptionDrospirenone is a synthetic progestin that is an analog to spironolactone. It is found in a number of birth control formulations. Drospirenone differs from other synthetic progestins in that its pharmacological profile in preclinical studies shows it to be closer to the natural progesterone. As such it has anti-mineralocorticoid properties, counteracts the estrogen-stimulated activity of the renin-angiotensin-aldosterone system, and is not androgenic. It was shown in animal studies that drospirenone exhibits antiandrogenic activity judging from accessory sex gland growth in castrated, androgen-treated, juvenile rats.
-
In VitroCell Cytotoxicity Assay Cell Line:PLHC-1 cell Concentration:10-150 μM Incubation Time:24 h, 48 h Result:Caused a 50% decline in cell viability with the effective concentration of 102-119 μM after 24 h exposure and 51-58 μM after 48 h exposure.
-
In VivoAnimal Model:Adult female mice Dosage:10 mg/kg, 100mg/kg Administration:Oral gavage (p.o.)Result:Caused DNA damage at dose rates of 10 and 100 mg/kg.Enhanced the genotoxicity combinated with ethinylestradiol.
-
Synonyms1,2-dihydro Spirorenone | ZK 30595
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor| COX-2| PR| Mineralocorticoid Receptor
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number67392-87-4
-
Formula Weight366.49
-
Molecular FormulaC24H30O3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 11 mg/mL (30.01 mM); DMSO: 73 mg/mL (199.18 mM)
-
SMILESO=C1CC[C@]2(C)[C@@]3([H])CC[C@@]([C@](OC4=O)(CC4)[C@]5([H])[C@@]6([H])C5)(C)[C@]6([H])[C@]3([H])C7C(C7)C2=C1
-
Chemical Name(2'S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,8dR,9aR)-4a,6a-dimethyl-4,4a,4b,5,6,6a,7a,8,8a,8b,8c,8d,9,9a-tetradecahydro-3'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-7,2'-furan]-2,5'(3H,4'H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bray JD, et al. J Steroid Biochem Mol Biol. 2005 Dec;97(4):328-4
molnova catalog



related products
-
JNJ63576253
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
-
VPC 14449
VPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM.
-
ARD-2128
ARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity.